Merck KGaA Purchases Cell Culture Supplier

BMI View: Mergers and acquisitions (M&A), rather than greenfield investments, will become more popular as a strategy for entry to the pharmaceutical industries of emerging markets. Merck KGaA's purchase of Beijing Skywing Technology will facilitate the sale of its subsidiary Merck Millipore's products throughout China, increasing the company's exposure to the market.

To read the full article, please choose one of the following options: